Cellular senescence and senotherapeutics in cardiovascular diseases
- 24 February 2025
- book chapter
- Published by Elsevier
- Vol. 104, 313-349
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Senolytic and senomorphic interventions to defy senescence-associated mitochondrial dysfunction2023
- RhoA rescues cardiac senescence by regulating Parkin-mediated mitophagyJournal of Biological Chemistry, 2023
- Is it the time of seno-therapeutics application in cardiovascular pathological conditions related to ageing?Current Research in Pharmacology and Drug Discovery, 2021
- Aging, MicroRNAs, and Heart FailureCurrent Problems in Cardiology, 2020
- Therapeutic Potential of Senolytics in Cardiovascular DiseaseCardiovascular Drugs and Therapy, 2020
- Targeting senescent cells to attenuate cardiovascular disease progressionAgeing Research Reviews, 2020
- Cellular Senescence: Defining a Path ForwardCell, 2019
- RETRACTED: Quercetin improve ischemia/reperfusion‐induced cardiomyocyte apoptosis in vitro and in vivo study via SIRT1/PGC‐1α signalingJournal of Cellular Biochemistry, 2019
- Lipid (per) oxidation in mitochondria: an emerging target in the ageing process?Biogerontology, 2017
- Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and AgingCell, 2017